Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction.

OBJECTIVES This study sought to determine the clinical and biological significance of elevated cardiac troponin T (cTnT) in patients with neuromuscular diseases. BACKGROUND Practice guidelines regard cTnT and cardiac troponin I (cTnI) as equally sensitive and specific for the diagnosis of myocardial injury. Although cTnI is unique to myocardium, cTnT can be re-expressed in skeletal muscle in response to injury. The commercial cTnT assay is claimed to be cardiac specific. METHODS Fifty-two patients with 20 different types of acquired and inherited neuromuscular diseases underwent full clinical assessment, cardiac investigations, and measurements of serum cTnT, cTnI, creatine kinase (CK), creatine kinase myocardial band (CK-MB), and N-terminal pro-B-type natriuretic peptide (NT-proBNP). RESULTS Serial measurements (265 samples) in 25 initially hospitalized patients taken during a mean of 2.4 years showed persistent elevation of cTnT (median: 0.08 μg/l; interquartile range: 0.06 to 0.14 μg/l), CK (582 U/l; 303 to 3,662 U/l), and CK-MB (24 μg/l; 8 to 34 μg/l). In contrast, cTnI, measured using 2 sensitive assays, was persistently normal throughout the study in 22 patients. Electrocardiograms (ECGs) and echocardiograms were normal in 16 and 17 patients, respectively, and no serial changes were observed. Therapeutic interventions in patients with reversible myopathies normalized cTnT, CK, and CK-MB in unison. Single measurements in 27 ambulatory patients showed elevated CK (953 U/l; 562 to 1,320 U/l), CK-MB (18 μg/l; 11 to 28 μg/l), and cTnT (0.03 μg/l; 0.02 to 0.05 μg/l) in 21, 22, and 18 patients respectively. cTnI was abnormal in only 1 patient. NT-proBNP (41 pg/ml; 35 to 97 pg/ml) was normal in all but 2 patients. ECGs were normal in 15 patients. No patients with elevated cTnT, but with normal cTnI, had any cardiovascular events in either group during follow-up. CONCLUSIONS Patients with a wide spectrum of neuromuscular diseases commonly have persistent elevation of cTnT and CK-MB in the absence of clinical and cTnI evidence of myocardial injury. Re-expressed cTnT in diseased skeletal muscle appears to be the source of the elevated cTnT detected in the circulation of these patients.

[1]  S. Solomon,et al.  Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. , 2013, Journal of the American College of Cardiology.

[2]  R. Twerenbold,et al.  Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. , 2014, European heart journal.

[3]  M. Yacoub,et al.  Troponin I gene expression during human cardiac development and in end-stage heart failure. , 1993, Circulation research.

[4]  A. Jaffe,et al.  Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. , 2011, Journal of the American College of Cardiology.

[5]  F. Apple,et al.  Cardiac troponin T composition in normal and regenerating human skeletal muscle. , 1997, Clinical chemistry.

[6]  M. Zhang,et al.  Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays. , 1999, Clinical chemistry.

[7]  J. Case,et al.  Serum Cardiac Troponin T, But Not Troponin I, Is Elevated in Idiopathic Inflammatory Myopathies , 2009, The Journal of Rheumatology.

[8]  Marc P. Bonaca,et al.  Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome. , 2014, Clinical chemistry.

[9]  N. Toyota,et al.  Isoforms of troponin during regeneration of chicken skeletal muscle fibers after cold injury , 2004, Cell and Tissue Research.

[10]  M. Petzold,et al.  Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. , 2013, Journal of the American College of Cardiology.

[11]  G. Dhoot,et al.  Identification of and pattern of transitions of cardiac, adult slow and slow skeletal muscle-like embryonic isoforms of troponin T in developing rat and human skeletal muscles , 1991, Journal of Muscle Research & Cell Motility.

[12]  F. Hagerman.  Reply to the Preceding Letter , 1983 .

[13]  A. Jaffe,et al.  Biochemical Markers of Myocardial Injury Is MB Creatine Kinase the Choice for the 1990s? , 1993, Circulation.

[14]  F. Apple,et al.  RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. , 1999, Clinical chemistry.

[15]  J. Finsterer,et al.  Cardiac and noncardiac, particularly neuromuscular, disease with troponin-T positivity. , 2007, The Netherlands journal of medicine.

[16]  J. Faulkner,et al.  The regeneration of skeletal muscle fibers following injury: a review. , 1983, Medicine and science in sports and exercise.

[17]  P. Allen,et al.  Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. , 1991, Circulation research.

[18]  D. Atar,et al.  Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction , 2000, Circulation.

[19]  A. Remppis,et al.  Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. , 1998, Clinical chemistry.

[20]  H. Baum,et al.  Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle. , 2000, American journal of clinical pathology.

[21]  F. Apple,et al.  Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. , 1995, Clinical chemistry.

[22]  B. Lindahl,et al.  The antibody configurations of cardiac troponin I assays may determine their clinical performance. , 2006, Clinical chemistry.

[23]  K. Pulkki,et al.  Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. , 2005, Clinical chemistry.

[24]  Stefan Blankenberg,et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction. , 2009, The New England journal of medicine.

[25]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[26]  J. Greenslade,et al.  Comparison of high sensitivity troponin T and I assays in the diagnosis of non-ST elevation acute myocardial infarction in emergency patients with chest pain. , 2014, Clinical biochemistry.

[27]  R. Luepker,et al.  Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes. , 2004, Clinical chemistry.

[28]  Robert C. Payne,et al.  Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction , 2000 .

[29]  F. Prinzen,et al.  Time-dependent degradation pattern of cardiac troponin T following myocardial infarction. , 2013, Clinical chemistry.

[30]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[31]  P. O’Rourke,et al.  Concordance, variance, and outliers in 4 contemporary cardiac troponin assays: implications for harmonization. , 2012, Clinical chemistry.

[32]  J. Mair,et al.  Clinical and experimental results on cardiac troponin expression in Duchenne muscular dystrophy. , 2001, Clinical chemistry.

[33]  A. Emery,et al.  Changes in creatine kinase and its isoenzymes in human fetal muscle during development , 1975, Journal of the Neurological Sciences.

[34]  R. Bischoff,et al.  Enhancement of skeletal muscle regeneration , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  K. Pulkki,et al.  Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. , 1997, Clinical chemistry.

[36]  F. Apple,et al.  Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. , 1998, Clinical chemistry.

[37]  A. Jaffe,et al.  Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.

[38]  H. Katus.  Development of the cardiac troponin T immunoassay. , 2008, Clinical chemistry.

[39]  G. Lum,et al.  False Positive Cardiac Troponin Results in Patients Without Acute Myocardial Infarction , 2006 .

[40]  M. Adamczyk,et al.  Coprevalence of autoantibodies to cardiac troponin I and T in normal blood donors. , 2010, Clinical chemistry.

[41]  S. Schiaffino,et al.  Cardiac troponin T in developing, regenerating and denervated rat skeletal muscle. , 1990, Development.

[42]  J. Alpert,et al.  Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .

[43]  M. Rudnicki,et al.  Cellular and molecular regulation of muscle regeneration. , 2004, Physiological reviews.

[44]  M. Panteghini,et al.  Standardisation of cardiac troponin I measurement: past and present , 2010, Pathology.

[45]  A. Wu,et al.  Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. , 1998, Clinical chemistry.

[46]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[47]  Jeroen J. Bax,et al.  The heart in sporadic inclusion body myositis: a study in 51 patients , 2009, Journal of Neurology.

[48]  M. Petzold,et al.  Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. , 2012, Clinical chemistry.

[49]  S. Blankenberg,et al.  Analytically false or true positive elevations of high sensitivity cardiac troponin: a systematic approach , 2013, Heart.

[50]  J. Mair,et al.  Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[51]  Mario Plebani,et al.  Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[52]  Marc P. Bonaca,et al.  Real-world application of "delta" troponin: diagnostic and prognostic implications. , 2013, Journal of the American College of Cardiology.

[53]  J. Arenas,et al.  Activities of creatine kinase and its isoenzymes in serum in various skeletal muscle disorders. , 1988, Clinical chemistry.

[54]  A. Oldfors,et al.  Raised troponin T in inclusion body myositis is common and serum levels are persistent over time , 2006, Neuromuscular Disorders.

[55]  H. Katus,et al.  Multicenter evaluation of a second-generation assay for cardiac troponin T. , 1997, Clinical chemistry.